Coherus BioSciences (CHRS) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free CHRS Stock Alerts $2.08 0.00 (0.00%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Coherus BioSciences Short Interest DataCurrent Short Interest21,690,000 sharesPrevious Short Interest21,530,000 sharesChange Vs. Previous Month+0.74%Dollar Volume Sold Short$42.51 millionShort Interest Ratio9.4 Days to CoverLast Record DateApril 30, 2024Outstanding Shares114,730,000 sharesPercentage of Shares Shorted18.91%Today's Trading Volume1,387,149 sharesAverage Trading Volume3,371,880 sharesToday's Volume Vs. Average41% Short Selling Coherus BioSciences ? Sign up to receive the latest short interest report for Coherus BioSciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCHRS Short Interest Over TimeCHRS Days to Cover Over TimeCHRS Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Coherus BioSciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202421,690,000 shares $42.51 million +0.7%N/A9.4 $1.96 4/15/202421,530,000 shares $47.37 million -8.2%N/A7.6 $2.20 3/31/202423,450,000 shares $56.05 million -9.5%N/A6.2 $2.39 3/15/202425,910,000 shares $57.52 million +7.1%N/A4.5 $2.22 2/29/202424,200,000 shares $55.18 million -4.4%N/A4.1 $2.28 2/15/202425,320,000 shares $72.16 million -10.0%N/A4.3 $2.85 Get the Latest News and Ratings for CHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202428,130,000 shares $60.48 million +2.6%N/A4.1 $2.15 1/15/202427,430,000 shares $70.50 million +13.2%N/A3.8 $2.57 12/31/202324,230,000 shares $80.69 million +1.9%N/A3.9 $3.33 12/15/202323,770,000 shares $51.58 million +10.8%N/A4.5 $2.17 11/30/202321,460,000 shares $45.71 million -1.1%N/A4.9 $2.13 11/15/202321,690,000 shares $39.04 million +9.3%N/A5.1 $1.80 10/31/202319,840,000 shares $66.46 million +6.0%N/A5.3 $3.35 10/15/202318,720,000 shares $71.32 million +6.4%N/A7 $3.81 9/30/202317,600,000 shares $65.82 million +21.1%N/A6.1 $3.74 9/15/202314,530,000 shares $71.49 million -7.2%N/A4.9 $4.92 8/31/202315,650,000 shares $83.41 million -0.3%N/A4.8 $5.33 8/15/202315,700,000 shares $70.18 million +16.7%N/A4.6 $4.47 7/31/202313,450,000 shares $64.83 million +6.9%N/A3.5 $4.82 7/15/202312,580,000 shares $51.07 million -16.4%N/A3.7 $4.06 6/30/202315,040,000 shares $64.22 million +15.4%N/A4.8 $4.27 6/15/202313,030,000 shares $70.23 million +0.2%N/A4.7 $5.39 5/31/202313,010,000 shares $53.21 million +9.3%N/A6.5 $4.09 5/15/202311,900,000 shares $58.19 million +12.9%N/A7.7 $4.89 4/30/202310,540,000 shares $76.20 million -4.1%N/A9.9 $7.23 4/15/202310,990,000 shares $86.60 million -7.3%N/A11.1 $7.88 3/31/202311,850,000 shares $81.05 million -1.7%N/A11.2 $6.84 3/15/202312,050,000 shares $77.00 million +22.5%N/A9.6 $6.39 2/28/20239,840,000 shares $66.62 million +0.8%N/A8 $6.77 2/15/20239,760,000 shares $77.01 million +2.3%13.4%8.5 $7.89 1/31/20239,540,000 shares $80.90 million -6.2%13.1%7.7 $8.48 1/15/202310,170,000 shares $106.28 million +2.1%14.0%8.1 $10.45 12/30/20229,960,000 shares $78.88 million +2.9%13.7%8 $7.92 12/15/20229,680,000 shares $71.15 million -4.4%13.3%9.2 $7.35 11/30/202210,130,000 shares $69.49 million +1.5%13.9%10 $6.86 11/15/20229,980,000 shares $79.44 million +7.1%13.7%9.2 $7.96 10/31/20229,320,000 shares $81.08 million +0.3%12.8%9 $8.70 10/15/20229,290,000 shares $76.92 million -3.4%12.8%8.6 $8.28 9/30/20229,620,000 shares $92.45 million +2.3%13.2%8.9 $9.61 9/15/20229,400,000 shares $98.98 million -1.2%12.9%8.5 $10.53This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 8/31/20229,510,000 shares $106.32 million -8.6%13.1%8.6 $11.18 8/15/202210,400,000 shares $144.25 million -1.8%14.3%9.8 $13.87 7/31/202210,590,000 shares $89.70 million +7.5%14.6%9.5 $8.47 7/15/20229,850,000 shares $78.50 million -10.4%13.6%9.2 $7.97 6/30/202210,990,000 shares $79.57 million +13.1%15.2%10.4 $7.24 6/15/20229,720,000 shares $58.22 million -4.6%13.4%9.4 $5.99 5/31/202210,190,000 shares $74.79 million +0.8%14.1%10.8 $7.34 5/15/202210,110,000 shares $80.37 million +16.2%14.0%11.1 $7.95 4/30/20228,700,000 shares $78.65 million +13.7%12.0%9.8 $9.04 4/15/20227,650,000 shares $85.99 million +0.1%10.6%8.7 $11.24 3/31/20227,640,000 shares $98.63 million +9.0%10.6%8.6 $12.91 3/15/20227,010,000 shares $87.91 million -1.3%9.7%8.1 $12.54 2/28/20227,100,000 shares $83.71 million -5.2%9.9%8.2 $11.79 2/15/20227,490,000 shares $98.87 million +13.8%10.4%8.6 $13.20 1/31/20226,580,000 shares $81.33 million -4.1%9.2%8.3 $12.36 1/15/20226,860,000 shares $95.35 million -3.7%9.6%9.7 $13.90 12/31/20217,120,000 shares $113.64 million +4.4%9.9%11.4 $15.96 12/15/20216,820,000 shares $117.24 million -4.5%9.5%10.6 $17.19 11/30/20217,140,000 shares $132.59 million +1.4%9.9%11.2 $18.57 11/15/20217,040,000 shares $133.20 million -6.3%9.8%10.9 $18.92 10/29/20217,510,000 shares $125.64 million -0.1%10.5%10.9 $16.73 10/15/20217,520,000 shares $127.84 million +1.5%10.5%11.5 $17.00 9/30/20217,410,000 shares $119.08 million -13.4%10.4%10.7 $16.07 9/15/20218,560,000 shares $135.16 million -11.9%12.0%12.9 $15.79 8/31/20219,720,000 shares $155.33 million +5.4%13.7%15.1 $15.98 8/13/20219,220,000 shares $128.43 million -1.3%13.0%13.5 $13.93 7/30/20219,340,000 shares $121.89 million +0.2%13.3%13.3 $13.05 7/15/20219,320,000 shares $122.37 million -2.0%13.2%12.4 $13.13 6/30/20219,510,000 shares $131.52 million -1.9%13.5%12.1 $13.83 6/15/20219,690,000 shares $136.73 million -3.2%13.8%11.1 $14.11 5/28/202110,010,000 shares $131.73 million -5.3%14.1%11.1 $13.16 5/14/202110,570,000 shares $146.82 million -5.4%N/A10 $13.89 4/30/202111,170,000 shares $164.20 million -16.8%16.4%10.3 $14.70 4/15/202113,420,000 shares $186.00 million -3.0%19.7%10.2 $13.86 3/31/202113,840,000 shares $199.99 million +1.9%20.3%10.2 $14.45 3/15/202113,580,000 shares $220.68 million +1.2%19.9%10 $16.25 2/26/202113,420,000 shares $204.66 million +2.6%19.7%10.2 $15.25 2/12/202113,080,000 shares $246.17 million -2.3%19.4%11.5 $18.82 1/29/202113,390,000 shares $259.77 million -11.3%19.8%12.2 $19.40 1/15/202115,100,000 shares $271.65 million -2.5%22.4%15.2 $17.99 12/31/202015,490,000 shares $272.16 million +6.1%22.9%17.6 $17.57 12/15/202014,600,000 shares $265.28 million -3.9%21.6%17.2 $18.17 11/30/202015,190,000 shares $282.84 million -3.6%22.5%17.2 $18.62 11/15/202015,760,000 shares $281.16 million -3.1%23.3%17.8 $17.84 10/30/202016,260,000 shares $278.86 million -3.0%24.1%17.9 $17.15 10/15/202016,770,000 shares $306.56 million -5.6%25.1%17.4 $18.28 9/30/202017,760,000 shares $325.72 million -5.9%26.5%18.4 $18.34 9/15/202018,870,000 shares $353.06 million +1.6%28.5%18.7 $18.71 8/31/202018,580,000 shares $352.46 million +3.2%28.1%17.4 $18.97 8/14/202018,010,000 shares $343.45 million -3.3%27.5%12.4 $19.07This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 7/31/202018,630,000 shares $327.70 million -3.8%28.5%12.3 $17.59 7/15/202019,370,000 shares $337.43 million +2.4%29.8%12.7 $17.42 6/30/202018,920,000 shares $327.88 million +3.4%29.1%10.6 $17.33 6/15/202018,290,000 shares $305.26 million +18.6%28.2%10.3 $16.69 5/29/202015,420,000 shares $281.42 million +10.0%23.8%8.4 $18.25 5/15/202014,020,000 shares $233.01 million +3.8%21.7%8.7 $16.62 4/30/202013,510,000 shares $224.27 million +26.7%20.9%8.9 $16.60 4/15/202010,660,000 shares $154.46 million -3.0%16.5%7.2 $14.49 3/31/202010,990,000 shares $190.46 million -5.4%17.0%8.9 $17.33 3/13/202011,618,200 shares $194.02 million -1.5%18.1%9.1 $16.70 2/28/202011,800,000 shares $167.91 million +1.5%18.3%11.1 $14.23 2/14/202011,630,000 shares $204.11 million +5.5%18.2%11.2 $17.55 1/31/202011,020,000 shares $224.59 million +2.3%17.3%10.2 $20.38 1/15/202010,770,000 shares $232.42 million +7.2%16.9%10.4 $21.58 12/31/201910,050,000 shares $182.41 million +6.7%15.8%9.5 $18.15 CHRS Short Interest - Frequently Asked Questions What is Coherus BioSciences' current short interest? Short interest is the volume of Coherus BioSciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 21,690,000 shares of CHRS short. Learn More on Coherus BioSciences' current short interest. What is a good short interest ratio for Coherus BioSciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CHRS shares currently have a short interest ratio of 9.0. Learn More on Coherus BioSciences's short interest ratio. Which institutional investors are shorting Coherus BioSciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Coherus BioSciences: Torno Capital LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Coherus BioSciences' short interest increasing or decreasing? Coherus BioSciences saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 21,690,000 shares, an increase of 0.7% from the previous total of 21,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Coherus BioSciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Coherus BioSciences: Monte Rosa Therapeutics, Inc. (6.01%), Agenus Inc. (16.80%), Zura Bio Limited (3.07%), Compass Therapeutics, Inc. (1.90%), Acumen Pharmaceuticals, Inc. (2.09%), Innate Pharma S.A. (0.10%), Sutro Biopharma, Inc. (2.38%), Opthea Limited (0.22%), INmune Bio, Inc. (13.54%), Poseida Therapeutics, Inc. (9.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Coherus BioSciences stock? Short selling CHRS is an investing strategy that aims to generate trading profit from Coherus BioSciences as its price is falling. CHRS shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Coherus BioSciences? A short squeeze for Coherus BioSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CHRS, which in turn drives the price of the stock up even further. How often is Coherus BioSciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHRS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: GLUE Short Interest Data AGEN Short Interest Data ZURA Short Interest Data CMPX Short Interest Data ABOS Short Interest Data IPHA Short Interest Data STRO Short Interest Data OPT Short Interest Data INMB Short Interest Data PSTX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CHRS) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Former CIA advisor: Dark side of AI now startingParadigm Press